OR-1896

OR-1896 is an inhibitor of PDE used in studies of Apoptosis. It is especially relevant in apoptosis, cancer, and cardiovascular models, where defined compound exposure can be linked to caspase-associated cell-death signaling and survival decisions.

By inhibiting PDE, OR-1896 can be used to examine caspase-associated cell-death signaling and survival decisions. The enzyme annotation adds relevance to enzyme-activity assays, substrate-conversion studies, and mechanism profiling, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and cardiovascular models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving PDE
• Pathway perturbation studies connected to Apoptosis
• Concentration-response inhibition and target-dependence studies
• Enzyme-activity assays, substrate-conversion studies, and mechanism profiling

Overall, OR-1896 is appropriate when a defined chemical perturbant is needed to connect PDE with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and cardiovascular models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.